LISATA THERAPEUTICS INC (LSTA)
US1280583022 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -20.74M | -20.84M | -54.23M | -27.47M | -8.14M | |||
| Depreciation Amortization | 182.00K | 189.00K | 70.00K | 60.00K | 60.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 670.00K | -462.00K | -830.00K | 650.00K | -2.32M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 993.00K | 1.08M | 33.82M | 4.52M | 1.57M | |||
| OPERATING CASH FLOW | -18.90M | -20.03M | -21.17M | -22.25M | -8.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -290.00K | -60.00K | -20.00K | |||
| Other Investing Activity | 6.13M | 10.10M | 29.20M | -54.84M | -7.26M | |||
| INVESTING CASH FLOW | 6.13M | 10.10M | 28.91M | -54.90M | -7.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 476.00K | 40.00K | 85.52M | 18.73M | |||
| Other Financing Activity | -143.00K | -91.00K | -270.00K | -250.00K | -150.00K | |||
| FINANCING CASH FLOW | -85.00K | 385.00K | -220.00K | 85.28M | 18.58M | |||
| Exchange Rate Effect | -66.00K | -16.00K | -10.00K | N/A | N/A | |||
| CHANGE IN CASH | -12.93M | -9.56M | 7.51M | 8.13M | 2.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.90M | -20.03M | -21.17M | -22.25M | -8.82M | |||
| Capital Expenditure | N/A | 0.00 | -290.00K | -60.00K | -20.00K | |||
| FREE CASH FLOW | -18.90M | -20.03M | -21.46M | -22.31M | -8.84M | |||
All data in USD